Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Yatin Suneja's Stock Ratings
Guggenheim Analyst
Yatin Suneja is an analyst at Guggenheim. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 09/14/2025
Overall Average Return
9.04%
Smart Score
Overall Average Return Percentile
55th
Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
09/10/2025 | TRML | Tourmaline Bio | $47.60 | 0.84% | $55 → $48 | Downgrade | Buy → Neutral | |||
09/09/2025 | DNTH | Dianthus Therapeutics | $38.25 | 161.44% | $92 → $100 | Maintains | Buy | |||
08/18/2025 | FBRX | Forte Biosciences | $10.56 | 610.23% | → $75 | Initiates | → Buy | |||
08/14/2025 | TRML | Tourmaline Bio | $47.60 | 15.55% | $55 → $55 | Reiterates | Buy → Buy | |||
08/08/2025 | CABA | Cabaletta Bio | $1.84 | 715.22% | $25 → $15 | Maintains | Buy | |||
08/04/2025 | REGN | Regeneron Pharmaceuticals | $561.51 | 45.14% | $810 → $815 | Maintains | Buy | |||
08/01/2025 | NBIX | Neurocrine Biosciences | $141.87 | 23.35% | $165 → $175 | Maintains | Buy | |||
08/01/2025 | ARGX | argenx | $756.38 | 41.46% | $1060 → $1070 | Maintains | Buy | |||
07/23/2025 | ABVX | Abivax | $81.84 | 23.41% | $50 → $101 | Maintains | Buy | |||
06/25/2025 | LRMR | Larimar Therapeutics | $4.05 | 541.98% | $26 → $26 | Reiterates | Buy → Buy | |||
06/24/2025 | LRMR | Larimar Therapeutics | $4.05 | 541.98% | $26 → $26 | Reiterates | Buy → Buy | |||
06/10/2025 | ALMS | Alumis | $4.52 | 298.23% | → $18 | Reinstates | → Buy | |||
05/28/2025 | ANAB | AnaptysBio | $23.40 | 284.62% | $54 → $90 | Maintains | Buy | |||
05/16/2025 | CABA | Cabaletta Bio | $1.84 | 1258.7% | $23 → $25 | Maintains | Buy | |||
05/15/2025 | CABA | Cabaletta Bio | $1.84 | 1258.7% | $23 → $25 | Maintains | Buy | |||
05/09/2025 | GHRS | GH Research | $11.94 | 142.88% | $32 → $29 | Maintains | Buy | |||
05/09/2025 | ARGX | argenx | $756.38 | 40.8% | $1100 → $1065 | Maintains | Buy | |||
05/06/2025 | ANAB | AnaptysBio | $23.40 | 130.77% | $52 → $54 | Maintains | Buy | |||
05/06/2025 | NBIX | Neurocrine Biosciences | $141.87 | 16.3% | $155 → $165 | Maintains | Buy | |||
05/02/2025 | PHAT | Phathom Pharmaceuticals | $11.95 | 0.42% | $18 → $12 | Maintains | Buy | |||
05/01/2025 | REGN | Regeneron Pharmaceuticals | $561.51 | 44.25% | $940 → $810 | Maintains | Buy | |||
04/02/2025 | PHAT | Phathom Pharmaceuticals | $11.95 | — | — | Reiterates | Buy → Buy | |||
04/01/2025 | CABA | Cabaletta Bio | $1.84 | 1150% | $23 → $23 | Reiterates | Buy → Buy | |||
03/26/2025 | ZURA | Zura Bio | $2.07 | 624.64% | $15 → $15 | Reiterates | Buy → Buy | |||
03/26/2025 | IFRX | InflaRx | $1.30 | 670.24% | $7 → $10 | Maintains | Buy | |||
03/25/2025 | LRMR | Larimar Therapeutics | $4.05 | 541.98% | $26 → $26 | Reiterates | Buy → Buy | |||
03/21/2025 | ACET | Adicet Bio | $0.81 | 763.98% | $7 → $7 | Reiterates | Buy → Buy | |||
03/20/2025 | IMVT | Immunovant | $16.23 | — | — | Reiterates | Buy → Buy | |||
03/12/2025 | DNTH | Dianthus Therapeutics | $38.25 | 119.61% | $84 → $84 | Reiterates | Buy → Buy | |||
03/12/2025 | ZBIO | Zenas BioPharma | $20.23 | 122.44% | $45 → $45 | Reiterates | Buy → Buy | |||
03/10/2025 | IMVT | Immunovant | $16.23 | — | — | Reiterates | Buy → Buy | |||
03/10/2025 | ARGX | argenx | $756.38 | 45.43% | $775 → $1100 | Maintains | Buy | |||
03/10/2025 | NMRA | Neumora Therapeutics | $1.62 | — | — | Downgrade | Buy → Neutral | |||
02/10/2025 | NBIX | Neurocrine Biosciences | $141.87 | 14.89% | $165 → $163 | Maintains | Buy | |||
02/10/2025 | IMVT | Immunovant | $16.23 | 171.1% | $46 → $44 | Maintains | Buy | |||
01/24/2025 | VIGL | Vigil Neuroscience | — | — | — | Reiterates | Buy → Buy | |||
01/03/2025 | ACAD | ACADIA Pharmaceuticals | $23.61 | -15.29% | $23 → $20 | Downgrade | Buy → Neutral | |||
01/03/2025 | ARGX | argenx | $756.38 | 2.46% | $665 → $775 | Maintains | Buy | |||
01/03/2025 | SRZN | Surrozen | $10.15 | 343.35% | $45 → $45 | Upgrade | Neutral → Buy | |||
12/12/2024 | ANAB | AnaptysBio | $23.40 | 53.85% | $90 → $36 | Maintains | Buy | |||
12/12/2024 | QTTB | Q32 Bio | $1.96 | — | — | Downgrade | Buy → Neutral | |||
12/11/2024 | TRML | Tourmaline Bio | $47.60 | — | — | Reiterates | Buy → Buy | |||
12/03/2024 | ZBIO | Zenas BioPharma | $20.23 | — | — | Reiterates | → Buy | |||
11/01/2024 | ARGX | argenx | $756.38 | -12.08% | $585 → $665 | Maintains | Buy | |||
10/25/2024 | SYRE | Spyre Therapeutics | $15.65 | 315.34% | $50 → $65 | Maintains | Buy | |||
10/21/2024 | ANAB | AnaptysBio | $23.40 | 284.62% | $75 → $90 | Maintains | Buy | |||
10/08/2024 | ZBIO | Zenas BioPharma | $20.23 | 122.44% | → $45 | Initiates | → Buy | |||
09/26/2024 | ARGX | argenx | $756.38 | -22.66% | $585 → $585 | Reiterates | Buy → Buy | |||
08/14/2024 | VIGL | Vigil Neuroscience | — | — | $17 → $16 | Maintains | Buy | |||
08/14/2024 | PRAX | Praxis Precision Medicine | $37.70 | 350.87% | $155 → $170 | Maintains | Buy | |||
08/02/2024 | NBIX | Neurocrine Biosciences | $141.87 | 26.88% | $170 → $180 | Maintains | Buy | |||
08/02/2024 | REGN | Regeneron Pharmaceuticals | $561.51 | 131.52% | $1180 → $1300 | Maintains | Buy | |||
07/26/2024 | ARGX | argenx | $756.38 | -22.66% | $545 → $585 | Maintains | Buy | |||
07/23/2024 | ALMS | Alumis | $4.52 | 607.96% | → $32 | Initiates | → Buy | |||
07/18/2024 | REGN | Regeneron Pharmaceuticals | $561.51 | 110.15% | $1040 → $1180 | Maintains | Buy | |||
06/18/2024 | PRAX | Praxis Precision Medicine | $37.70 | 311.09% | → $155 | Initiates | → Buy | |||
06/17/2024 | QTTB | Q32 Bio | $1.96 | 5002.04% | → $100 | Initiates | → Buy | |||
05/10/2024 | RAPT | RAPT Therapeutics | $16.22 | — | — | Downgrade | Buy → Neutral | |||
05/02/2024 | NBIX | Neurocrine Biosciences | $141.87 | 19.83% | $164 → $170 | Maintains | Buy | |||
04/29/2024 | ABVX | Abivax | $81.84 | -38.91% | → $50 | Initiates | → Buy | |||
02/27/2024 | CLDX | Celldex Therapeutics | $24.80 | 262.9% | $72 → $90 | Maintains | Buy | |||
02/21/2024 | AXSM | Axsome Therapeutics | $118.42 | 5.56% | $110 → $125 | Maintains | Buy | |||
01/02/2024 | LBPH | Longboard Pharmaceuticals | — | — | $16 → $32 | Maintains | Buy | |||
12/22/2023 | KRTX | Karuna Therapeutics | — | — | — | Downgrade | Buy → Neutral | |||
11/15/2023 | ROIV | Roivant Sciences | $14.00 | 14.28% | $17 → $16 | Maintains | Buy | |||
11/15/2023 | MLTX | MoonLake | $54.36 | 41.65% | $70 → $77 | Maintains | Buy | |||
10/31/2023 | TRML | Tourmaline Bio | $47.60 | 5.04% | → $50 | Initiates | → Buy | |||
10/17/2023 | ROIV | Roivant Sciences | $14.00 | 21.42% | → $17 | Initiates | → Buy | |||
10/10/2023 | NMRA | Neumora Therapeutics | $1.62 | 1258.02% | → $22 | Initiates | → Buy | |||
09/22/2023 | SEEL | Seelos Therapeutics | — | — | — | Downgrade | Buy → Neutral | |||
09/22/2023 | IMVT | Immunovant | $16.23 | 97.17% | → $32 | Reiterates | Buy → Buy | |||
09/21/2023 | SEEL | Seelos Therapeutics | — | — | — | Downgrade | Buy → Neutral | |||
08/14/2023 | CABA | Cabaletta Bio | $1.84 | 1747.83% | → $34 | Reiterates | Buy → Buy | |||
07/28/2023 | ARGX | argenx | $756.38 | -22% | $545 → $590 | Maintains | Buy | |||
07/18/2023 | ARGX | argenx | $756.38 | -27.95% | $505 → $545 | Maintains | Buy | |||
07/18/2023 | CABA | Cabaletta Bio | $1.84 | 1747.83% | → $34 | Initiates | → Buy | |||
07/17/2023 | REGN | Regeneron Pharmaceuticals | $561.51 | 60.28% | $935 → $900 | Maintains | Buy | |||
07/17/2023 | BTAI | BioXcel Therapeutics | $3.17 | — | — | Downgrade | Buy → Neutral | |||
06/26/2023 | MLTX | MoonLake | $54.36 | 19.57% | $51 → $65 | Maintains | Buy | |||
06/22/2023 | ZURA | Zura Bio | $2.07 | 866.18% | → $20 | Initiates | → Buy | |||
06/15/2023 | XENE | Xenon Pharmaceuticals | $36.21 | 35.32% | → $49 | Reiterates | Buy → Buy | |||
06/15/2023 | AXSM | Axsome Therapeutics | $118.42 | -7.11% | → $110 | Reiterates | Buy → Buy | |||
05/23/2023 | IMVT | Immunovant | $16.23 | 97.17% | $30 → $32 | Maintains | Buy | |||
05/18/2023 | EYPT | EyePoint Pharmaceuticals | $13.30 | 313.53% | $52 → $55 | Maintains | Buy | |||
05/17/2023 | LRMR | Larimar Therapeutics | $4.05 | 245.68% | $12 → $14 | Maintains | Buy | |||
05/12/2023 | ANAB | AnaptysBio | $23.40 | 92.31% | $44 → $45 | Maintains | Buy | |||
05/09/2023 | BTAI | BioXcel Therapeutics | $3.17 | 1351.1% | $50 → $46 | Maintains | Buy | |||
05/09/2023 | AXSM | Axsome Therapeutics | $118.42 | -15.55% | $90 → $100 | Maintains | Buy | |||
05/08/2023 | REGN | Regeneron Pharmaceuticals | $561.51 | 66.52% | $960 → $935 | Maintains | Buy | |||
05/04/2023 | NBIX | Neurocrine Biosciences | $141.87 | 2.21% | → $145 | Upgrade | Neutral → Buy | |||
05/01/2023 | MLTX | MoonLake | $54.36 | -6.18% | → $51 | Initiates | → Buy | |||
05/01/2023 | BIIB | Biogen | $146.01 | 139.71% | $270 → $350 | Upgrade | Neutral → Buy | |||
04/17/2023 | RXDX | Prometheus Biosciences | — | — | $225 → $200 | Downgrade | Buy → Neutral | |||
04/06/2023 | IFRX | InflaRx | $1.30 | — | — | Upgrade | Neutral → Buy | |||
04/05/2023 | IFRX | InflaRx | $1.30 | 516.19% | → $8 | Upgrade | Neutral → Buy | |||
03/15/2023 | RAPT | RAPT Therapeutics | $16.22 | 195.93% | $55 → $48 | Maintains | Buy | |||
03/15/2023 | LRMR | Larimar Therapeutics | $4.05 | 196.3% | → $12 | Reiterates | → Buy | |||
03/06/2023 | RXDX | Prometheus Biosciences | — | — | $185 → $225 | Maintains | Buy | |||
02/28/2023 | AXSM | Axsome Therapeutics | $118.42 | -24% | $105 → $90 | Maintains | Buy | |||
02/13/2023 | IMVT | Immunovant | $16.23 | — | — | Upgrade | Neutral → Buy | |||
01/04/2023 | RAPT | RAPT Therapeutics | $16.22 | 239.09% | → $55 | Initiates | → Buy | |||
01/03/2023 | ACAD | ACADIA Pharmaceuticals | $23.61 | -6.82% | → $22 | Upgrade | Neutral → Buy | |||
01/03/2023 | SAGE | Sage Therapeutics | — | — | — | Downgrade | Buy → Neutral | |||
12/13/2022 | HZNP | Horizon Therapeutics | — | — | $98 → $116.5 | Downgrade | Buy → Neutral | |||
11/18/2022 | SRZN | Surrozen | $10.15 | — | — | Downgrade | Buy → Neutral | |||
11/11/2022 | XENE | Xenon Pharmaceuticals | $36.21 | 35.32% | $53 → $49 | Maintains | Buy | |||
11/11/2022 | VIGL | Vigil Neuroscience | — | — | $22 → $19 | Maintains | Buy | |||
11/11/2022 | SAGE | Sage Therapeutics | — | — | $55 → $48 | Maintains | Buy | |||
11/11/2022 | REGN | Regeneron Pharmaceuticals | $561.51 | 62.95% | $925 → $915 | Maintains | Buy | |||
11/11/2022 | PHAT | Phathom Pharmaceuticals | $11.95 | 151.05% | $42 → $30 | Maintains | Buy | |||
11/11/2022 | LBPH | Longboard Pharmaceuticals | — | — | $18 → $16 | Maintains | Buy | |||
11/11/2022 | EYPT | EyePoint Pharmaceuticals | $13.30 | 290.98% | $60 → $52 | Maintains | Buy | |||
11/11/2022 | CLDX | Celldex Therapeutics | $24.80 | 154.03% | $68 → $63 | Maintains | Buy | |||
11/11/2022 | BTAI | BioXcel Therapeutics | $3.17 | 688.64% | $28 → $25 | Maintains | Buy | |||
11/11/2022 | BIIB | Biogen | $146.01 | 84.92% | $265 → $270 | Maintains | Neutral | |||
11/11/2022 | AXSM | Axsome Therapeutics | $118.42 | -32.44% | $72 → $80 | Maintains | Buy | |||
11/01/2022 | ANAB | AnaptysBio | $23.40 | — | — | Upgrade | Neutral → Buy | |||
10/19/2022 | RETA | Reata Pharmaceuticals | — | — | → $75 | Initiates | → Buy | |||
10/19/2022 | LRMR | Larimar Therapeutics | $4.05 | 196.3% | → $12 | Initiates | → Buy | |||
10/14/2022 | AXSM | Axsome Therapeutics | $118.42 | -39.2% | $64 → $72 | Maintains | Buy | |||
10/14/2022 | RLMD | Relmada Therapeutics | $1.54 | — | — | Downgrade | Buy → Neutral | |||
09/06/2022 | RLMD | Relmada Therapeutics | $1.54 | 3796.1% | $50 → $60 | Maintains | Buy | |||
08/12/2022 | KRTX | Karuna Therapeutics | — | — | $200 → $330 | Maintains | Buy | |||
05/31/2022 | BLCO | Bausch & Lomb | $15.19 | 58% | → $24 | Initiates | → Buy | |||
04/26/2022 | ELYM | Eliem Therapeutics | — | — | — | Downgrade | Buy → Neutral | |||
03/22/2022 | ANAB | AnaptysBio | $23.40 | — | — | Downgrade | Buy → Neutral | |||
01/13/2022 | BIIB | Biogen | $146.01 | 38.35% | $290 → $202 | Downgrade | Buy → Neutral | |||
12/21/2021 | ACAD | ACADIA Pharmaceuticals | $23.61 | 18.59% | → $28 | Downgrade | Buy → Neutral | |||
11/01/2021 | ACAD | ACADIA Pharmaceuticals | $23.61 | -2.58% | → $23 | Upgrade | Neutral → Buy | |||
10/29/2021 | ARGX | argenx | $756.38 | -56.37% | → $330 | Upgrade | Neutral → Buy | |||
09/15/2021 | SRZN | Surrozen | $10.15 | 97.04% | → $20 | Initiates | → Buy | |||
09/07/2021 | ELYM | Eliem Therapeutics | — | — | → $32 | Initiates | → Buy | |||
07/22/2021 | CLDX | Celldex Therapeutics | $24.80 | 166.13% | → $66 | Initiates | → Buy | |||
07/01/2021 | SEEL | Seelos Therapeutics | — | — | → $8 | Initiates | → Buy | |||
06/01/2021 | IMVT | Immunovant | $16.23 | — | — | Downgrade | Buy → Neutral | |||
04/06/2021 | RXDX | Prometheus Biosciences | — | — | → $40 | Initiates | → Buy | |||
04/06/2021 | LBPH | Longboard Pharmaceuticals | — | — | → $27 | Initiates | → Buy | |||
03/11/2021 | IFRX | InflaRx | $1.30 | 1132.38% | → $16 | Upgrade | Neutral → Buy | |||
03/09/2021 | ACAD | ACADIA Pharmaceuticals | $23.61 | — | — | Downgrade | Buy → Neutral | |||
02/02/2021 | PHAT | Phathom Pharmaceuticals | $11.95 | 402.09% | → $60 | Initiates | → Buy | |||
01/04/2021 | SAGE | Sage Therapeutics | — | — | — | Upgrade | Neutral → Buy | |||
10/14/2020 | ANAB | AnaptysBio | $23.40 | 53.85% | → $36 | Upgrade | Neutral → Buy | |||
10/12/2020 | IMVT | Immunovant | $16.23 | 288.17% | → $63 | Initiates | → Buy | |||
05/27/2020 | ARGX | argenx | $756.38 | -70.25% | $201 → $225 | Reiterates | → Buy | |||
04/08/2020 | SAGE | Sage Therapeutics | — | — | — | Downgrade | Buy → Neutral | |||
03/03/2020 | ANAB | AnaptysBio | $23.40 | -40.17% | $15 → $14 | Maintains | Hold | |||
01/14/2020 | VRNA | Verona Pharma | $106.43 | -68.05% | $29 → $34 | Maintains | Buy | |||
12/16/2019 | RLMD | Relmada Therapeutics | $1.54 | 4055.84% | → $64 | Initiates | → Buy | |||
12/16/2019 | AXSM | Axsome Therapeutics | $118.42 | 33.42% | $65 → $158 | Maintains | Buy | |||
12/16/2019 | ACAD | ACADIA Pharmaceuticals | $23.61 | 154.13% | → $60 | Initiates | → Buy | |||
11/08/2019 | ANAB | AnaptysBio | $23.40 | — | — | Downgrade | Buy → Neutral | |||
10/16/2019 | AXSM | Axsome Therapeutics | $118.42 | -59.47% | → $48 | Initiates | → Buy | |||
06/24/2019 | ANAB | AnaptysBio | $23.40 | 297.44% | $125 → $93 | Maintains | Buy | |||
02/22/2019 | GBT | Global Blood Therapeutics | — | — | — | Initiates | → Buy | |||
02/22/2019 | ARGX | argenx | $756.38 | -79.24% | → $157 | Initiates | → Buy | |||
02/22/2019 | ANAB | AnaptysBio | $23.40 | — | — | Initiates | → Buy | |||
02/22/2019 | IFRX | InflaRx | $1.30 | — | — | Initiates | → Buy | |||
02/22/2019 | SAGE | Sage Therapeutics | — | — | → $205 | Initiates | → Buy | |||
06/11/2018 | SGEN | Seagen | — | — | $60 → $80 | Upgrade | Neutral → Buy | |||
11/15/2017 | ANAB | AnaptysBio | $23.40 | 391.45% | → $115 | Initiates | → Buy | |||
05/22/2017 | VRNA | Verona Pharma | $106.43 | -75.57% | → $26 | Initiates | → Buy | |||
03/07/2016 | CLDX | Celldex Therapeutics | $24.80 | — | — | Downgrade | Buy → Neutral | |||
03/02/2016 | SGEN | Seagen | — | — | → $34 | Initiates | → Neutral | |||
07/03/2013 | CLDX | Celldex Therapeutics | $24.80 | -3.23% | → $24 | Initiates | → Buy |
